Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis Generalized”

142 trials

Showing 20 of 142 results

Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Not applicableLooking for participantsNCT06909253
What this trial is testing

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
AstraZeneca 50
Not applicableNot Yet RecruitingNCT07337395
What this trial is testing

Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab

Who this might be right for
Myasthenia Gravis Generalised
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 24
Large-scale testing (Phase 3)Study completedNCT04225871
What this trial is testing

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 200
Early research (Phase 1)Not Yet RecruitingNCT06759948
What this trial is testing

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Chongbo Zhao 18
Large-scale testing (Phase 3)Study completedNCT03920293
What this trial is testing

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 175
Large-scale testing (Phase 3)Looking for participantsNCT06193889
What this trial is testing

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia GravisGeneralized Myasthenia Gravis
Kyverna Therapeutics 66
Large-scale testing (Phase 3)Looking for participantsNCT06447597
What this trial is testing

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

Who this might be right for
Generalized Myasthenia Gravis
Shanghai Jiaolian Drug Research and Development Co., Ltd 104
Testing effectiveness (Phase 2)Study completedNCT02473965
What this trial is testing

Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Grifols Therapeutics LLC 60
Large-scale testing (Phase 3)Study completedNCT00408213
What this trial is testing

A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.

Who this might be right for
Myasthenia Gravis Generalised
Hoffmann-La Roche 136
Large-scale testing (Phase 3)Ended earlyNCT04963270
What this trial is testing

Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Hoffmann-La Roche 188
Large-scale testing (Phase 3)Looking for participantsNCT07217587
What this trial is testing

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Janssen Research & Development, LLC 115
Testing effectiveness (Phase 2)Study completedNCT02965573
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Who this might be right for
Myasthenia Gravis
argenx 24
Testing effectiveness (Phase 2)Study completedNCT04159805
What this trial is testing

TAK-079 in People With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Takeda 36
Very early researchUnknownNCT01555580
What this trial is testing

A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Muscular Dystrophy Association 12
Early research (Phase 1)Active Not RecruitingNCT06958939
What this trial is testing

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Ting Chang, MD 10
Large-scale testing (Phase 3)Study completedNCT01997229
What this trial is testing

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 125
Testing effectiveness (Phase 2)WithdrawnNCT04982289
What this trial is testing

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07818291
What this trial is testing

An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Shanghai Lanyi Therapeutics Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07501702
What this trial is testing

Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Vertex Pharmaceuticals Incorporated 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation